Hyundai Bioscience Develops Injection Drug for Potential Treatment of Severe Cases of COVID-19 Society December 23, 2020 Hyundai Bioscience announced on the 23rd, December 2020, that CNPharm, its major shareholding bio tech company, has succeeded in developing…
